Back to today’s briefing

Story perspectives

Over Half of Online GLP-1 Sellers Mislead Consumers

1/18/2025

33 7

Summary

Story summary

A recent JAMA Health Forum study uncovers alarming truths about online sellers of compounded GLP-1 receptor agonists. More than half of the 79 websites examined misled consumers by neglecting to mention the absence of FDA approval, exaggerating benefits, and downplaying risks. Experts are calling for tighter regulations to safeguard patient health.

1 of 1

Story summary

A recent JAMA Health Forum study uncovers alarming truths about online sellers of compounded GLP-1 receptor agonists. More than half of the 79 websites examined misled consumers by neglecting to mention the absence of FDA approval, exaggerating benefits, and downplaying risks. Experts are calling for tighter regulations to safeguard patient health.